Can Winlevi and Arazlo Be Prescribed Together?
Yes, Winlevi (clascoterone) and Arazlo (tazarotene) can be prescribed together for acne treatment, as this combination aligns with guideline-recommended multimodal therapy using complementary mechanisms of action. 1
Rationale for Combination Therapy
The 2024 American Academy of Dermatology guidelines explicitly recommend multimodal therapy combining multiple mechanisms of action when managing acne with topical medications. 1 This approach is considered a good practice statement, meaning it represents fundamental clinical practice for optimal acne management.
Complementary Mechanisms
Clascoterone (Winlevi) is a topical androgen receptor inhibitor that reduces sebum production by blocking androgen effects on sebaceous glands. 2, 3
Tazarotene (Arazlo) is a topical retinoid that normalizes keratinocyte differentiation, reverses keratinocyte hyperproliferation, and has anti-inflammatory effects. 4
These two agents target different pathways in acne pathogenesis, making them theoretically synergistic rather than redundant. 1
Important Safety Considerations
Skin Irritation Management
Both medications can cause local skin reactions, so careful monitoring is essential:
Arazlo commonly causes application site pain, dryness, exfoliation, erythema, and pruritus, with maximum severity typically peaking at Week 2 of therapy. 5
Clascoterone is generally well-tolerated with occasional localized skin irritation. 2, 3
When combining these agents, instruct patients to use moisturizers liberally and consider reducing application frequency if irritation becomes moderate to severe. 5
Avoid concomitant use of other medications and cosmetics with strong drying effects until the skin adjusts to treatment. 5
Photosensitivity Precautions
Arazlo increases photosensitivity, requiring patients to minimize unprotected UV exposure, use sunscreen products, and wear protective clothing over treated areas. 5
Advise patients not to use Arazlo until fully recovered from sunburn. 5
Exercise caution if the patient is taking photosensitizing drugs (thiazides, tetracyclines, fluoroquinolones, phenothiazines, sulfonamides). 5
Pregnancy Considerations
Arazlo is contraindicated in pregnancy due to teratogenic risk and requires pregnancy testing within 2 weeks prior to therapy, initiation during a menstrual period, and effective contraception during treatment. 5
Clascoterone has demonstrated low systemic absorption in pharmacokinetic studies, but pregnancy precautions should still be discussed. 6
Practical Application Strategy
Timing and Application
Apply the medications at different times of day to minimize cumulative irritation (e.g., clascoterone in the morning, tazarotene in the evening). 7
Start with alternate-day application of tazarotene if the patient has sensitive skin, then increase frequency as tolerated. 4
Clascoterone is typically applied twice daily for optimal results. 7, 8
Monitoring
Assess for local skin reactions at 2-week intervals initially, as this is when irritation peaks with retinoid therapy. 5
Evaluate treatment response at 12 weeks, as both medications demonstrate significant efficacy by this timepoint. 8
Common Pitfalls to Avoid
Do not combine tazarotene with benzoyl peroxide at the same application time, as oxidizing agents cause degradation of tazarotene and reduce clinical efficacy. 5 If benzoyl peroxide is needed, apply it at a different time of day than the tazarotene.
Avoid applying either medication to eczematous or sunburned skin. 5
Do not discontinue moisturizer use—it is essential for tolerability when combining these agents. 5